Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead to work with Merck on combination of Trodelvy and Keytruda for lung cancer
02:27pm, Monday, 10'th Jan 2022 Seeking Alpha
Gilead Sciences (pembrolizumab) is partnering with Merck to examine a combination of the former''s Trodelvy with the latter''s Keytruda (pembrolizumab) for first-line NSCLC.
Everest Medicines Will Participate in a Clinical Trial with Gilead and MSD to Evaluate Trodelvy® in Combination with KEYTRUDA® (pembrolizumab) in First-Line Metastatic Non-Small Cell Lung Cancer
01:35pm, Monday, 10'th Jan 2022 Business Insider Markets
SHANGHAI, Jan. 1 0, 202 2 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), today
Gilead CEO: Oral version of Covid drug Remdesivir in early testing
11:36am, Monday, 10'th Jan 2022
Gilead CEO Daniel O'Day sits down with CNBC's Meg Tirrell and the 'Squawk on the Street' team to discuss the company's Covid-19 antiviral, Remdesivir.
Fridays Top Analyst Upgrades and Downgrades: Comerica, CrowdStrike, Exxon, Ford, Gilead, Goldman Sachs, Lowes, Lyft, Palo Alto Networks and More
01:59pm, Friday, 07'th Jan 2022 24/7 Wall street7 Safe Stocks for Your Retirement
12:46pm, Friday, 07'th Jan 2022
In a dynamic market like the one we're in now, it's important to buy safe stocks that will build your nest egg in the years to come. The post 7 Safe Stocks for Your Retirement appeared first on Invest
Arcus Biosciences: Not Much Data Yet, But Gilead Deal Is A Huge Value Add
10:21am, Friday, 07'th Jan 2022 Seeking AlphaArcus Biosciences: Not Much Data Yet, But Gilead Deal Is A Huge Value Add
05:21am, Friday, 07'th Jan 2022
Arcus Biosciences: Not Much Data Yet, But Gilead Deal Is A Huge Value Add
Gilead: Veklury Revenues Set To Impress
09:15pm, Thursday, 06'th Jan 2022
This follow-up article to our September 2021 piece shows that Gilead is set to blow past revenue guidance and analyst estimates once again through increasing Veklury sales. New COVID cases and hospita
Gilead Sciences: A Good Pick For Value And Dividend Investors
12:04pm, Thursday, 06'th Jan 2022 Seeking Alpha7 Pharmaceutical Stocks That Could Make You Rich
07:56am, Thursday, 06'th Jan 2022
These seven pharmaceutical stocks could create lucrative opportunities in the new year The post 7 Pharmaceutical Stocks That Could Make You Rich appeared first on InvestorPlace. More From InvestorPlac
Gilead Sciences: A Good Pick For Value And Dividend Investors
07:04am, Thursday, 06'th Jan 2022
Gilead Sciences is reporting high growth rates, but this growth mostly stems from Veklury sales, and when the pandemic ends, these sales will decline steeply. Nevertheless, we can assume that Gilead S
Why Gilead (GILD) is Poised to Beat Earnings Estimates Again
01:49pm, Wednesday, 05'th Jan 2022
Gilead (GILD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2 Top Dividend Stocks That Are Yielding More Than 3%
10:30am, Wednesday, 05'th Jan 2022
They pay more than double the S&P 500 average.
Gilead Sciences Inc. stock falls Friday, underperforms market
09:56pm, Friday, 31'st Dec 2021 MarketWatch
Shares of Gilead Sciences Inc. slid 1.02% to $72.61 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500
